These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 1479960

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Virulence factors in Bacteroides fragilis group.
    Jotwani R, Gupta U.
    Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL, Onderdonk AB.
    Scand J Infect Dis Suppl; 1982 Jul; 31():28-33. PubMed ID: 6954635
    [Abstract] [Full Text] [Related]

  • 5. Pathogenicity of the Bacteroides fragilis group.
    Brook I.
    Ann Clin Lab Sci; 1989 Jul; 19(5):360-76. PubMed ID: 2679351
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB, Shapiro ME, Finberg RW, Zaleznik DF, Kasper DL.
    Rev Infect Dis; 1984 Jul; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB, Kasper DL, Cisneros RL, Bartlett JG.
    J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intestinal bacteria translocate into experimental intra-abdominal abscesses.
    Wells CL, Rotstein OD, Pruett TL, Simmons RL.
    Arch Surg; 1986 Jan; 121(1):102-7. PubMed ID: 3510604
    [Abstract] [Full Text] [Related]

  • 13. Animal model system for studying virulence of and host response to Bacteroides fragilis.
    Onderdonk AB, Cisneros RL, Finberg R, Crabb JH, Kasper DL.
    Rev Infect Dis; 1990 Jan; 12 Suppl 2():S169-77. PubMed ID: 2406869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I.
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Encapsulated strains of Bacteroides fragilis in clinical specimens.
    Lindberg AA, Berthold P, Nord CE, Weintraub A.
    Med Microbiol Immunol; 1979 Mar 13; 167(1):29-36. PubMed ID: 440201
    [Abstract] [Full Text] [Related]

  • 18. Adherence of Bacteroides fragilis in vivo.
    Onderdonk AB, Moon NE, Kasper DL, Bartlett JG.
    Infect Immun; 1978 Mar 13; 19(3):1083-7. PubMed ID: 640723
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Experimental Bacteroides fragilis keratitis.
    Stern GA, Stock EL.
    Arch Ophthalmol; 1978 Dec 13; 96(12):2264-6. PubMed ID: 718520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.